A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence has revealed that the UK has the strongest research and development (R&D) pipeline in Europe.
UK hub for science
Additionally, the report — ‘Pipeline Progressing: the UK’s global bioscience cluster in 2017’ — has revealed that more of the country’s biotech companies are maturing and moving through the financing life cycle with UK biotech IPOs raising over double the money in 2017 compared with 2016.